Atypical Progeroid Syndrome and Partial Lipodystrophy Due to LMNA Gene p.R349W Mutation

التفاصيل البيبلوغرافية
العنوان: Atypical Progeroid Syndrome and Partial Lipodystrophy Due to LMNA Gene p.R349W Mutation
المؤلفون: Giovanni Ceccarini, Annamaria Ciccarone, Andrea Barison, Maria Rita Sessa, Margherita Maffei, Ferruccio Santini, Gianluca Aimaretti, Silvia Magno, Caterina Pelosini, Federica Ferrari, Michele Emdin, Donatella Gilio, Flavia Prodam
المصدر: Journal of the Endocrine Society
بيانات النشر: The Endocrine Society, 2020.
سنة النشر: 2020
مصطلحات موضوعية: 0301 basic medicine, Pathology, medicine.medical_specialty, lipodystrophy, Heart disease, Endocrinology, Diabetes and Metabolism, Cardiomyopathy, Case Report, 030209 endocrinology & metabolism, Short stature, Nephropathy, LMNA, 03 medical and health sciences, 0302 clinical medicine, Medicine, Missense mutation, LMNA mutation, business.industry, Partial Lipodystrophy, atypical progeroid syndrome, medicine.disease, 030104 developmental biology, Atypical progeroid syndrome, Lipodystrophy, medicine.symptom, business, AcademicSubjects/MED00250
الوصف: Atypical progeroid syndrome (APS) comprises heterogeneous disorders characterized by variable degrees of fat loss, metabolic alterations, and comorbidities that affect skeleton, muscles, and/or the heart. We describe 3 patients that were referred to our center for the suspicion of lipodystrophy. They had precocious aging traits such as short stature, mandibular hypoplasia, beaked nose, and partial alopecia manifesting around 10 to 15 years of age recurrently associated with: (1) partial lipodystrophy; (2) proteinuric nephropathy; (3) heart disease (rhythm disorders, valvular abnormalities, and cardiomyopathy); and (4) sensorineural hearing impairment. In all patients, genetic testing revealed a missense heterozygous lamin A/C gene (LMNA) mutation c.1045 C > T (p.Arg349Trp). Ten patients with LMNA p.R349W mutation have been reported so far, all presenting with similar features, which represent the key pathological hallmarks of this subtype of APS. The associated kidney and cardiac complications occurring in the natural history of the disease may reduce life expectancy. Therefore, in these patients a careful and periodic cardiac and kidney function evaluation is required.
تدمد: 2472-1972
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11258f7e1c46efe2954ed906fdda4d1dTest
https://doi.org/10.1210/jendso/bvaa108Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....11258f7e1c46efe2954ed906fdda4d1d
قاعدة البيانات: OpenAIRE